TRIPLE CONTRAST COMPUTED TOMOGRAPHY REVEALS SITE-SPECIFIC BIOMECHANICAL DIFFERENCES IN HUMAN KNEE JOINT - A PROOF OF CONCEPT STUDY.

Cartilage and synovial fluid are challenging to observe separately in native computed tomography (CT). We report the use of triple contrast agent (bismuth nanoparticles, CA4+, and gadoteridol) to image and segment cartilage in cadaveric knee joints with a clinical CT scanner. We hypothesize that bismuth nanoparticles will remain in synovial fluid while the CA4+ and gadoteridol will diffuse into cartilage, allowing 1) segmentation of cartilage, and 2) evaluation of cartilage biomechanical properties based on contrast agent concentrations. To investigate these hypotheses, triple contrast agent was injected into both knee joints of a cadaver (N = 1), imaged with a clinical CT at multiple timepoints during the contrast agent diffusion. Knee joints were extracted, imaged with µCT, and biomechanical properties of the cartilage surface were determined by stress-relaxation mapping. Cartilage was segmented and contrast agent concentrations (CA4+ and gadoteridol) were compared with the biomechanical properties at multiple locations (n = 185). Spearman's correlation between cartilage thickness from clinical CT and reference µCT images verifies successful and reliable segmentation. CA4+ concentration is significantly higher in femoral than in tibial cartilage at 60-min and further timepoints, which corresponds to the higher Young's modulus observed in femoral cartilage. In this pilot study, we show that 1) large bismuth nanoparticles do not diffuse into cartilage, facilitating straightforward segmentation of human knee joint cartilage in a clinical setting, and 2) CA4+ concentration in cartilage reflects the biomechanical differences between femoral and tibial cartilage. Thus, the triple contrast agent CT shows potential in cartilage morphology and condition estimation in clinical CT. This article is protected by copyright. All rights reserved.